Long-term pharmacological or genetic NOS inhibition mitigates PAH in caveolin-1-deficient mice (Wunderlich et al. 2008a; Zhao et al. 2009), possibly because NO is a substrate in the PKG nitration reaction. The gene discussed is CAV1; the disease is pulmonary arterial hypertension.